Literature DB >> 16636644

Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong.

Christy Lm Hui1, Eric Yh Chen, Cs Kan, Kc Yip, Cw Law, Cindy Py Chiu.   

Abstract

OBJECTIVE: Adherence to antipsychotic treatment is an important aspect of long term management of schizophrenia and other related psychotic disorders. The evaluation of adherence is often difficult in clinical settings. This study compared patients self-reports and clinician judgment of adherence behavior and explored their relationship with attitudes toward taking medication.
METHODS: Clinician rated questionnaire and matching patient self rated questionnaires were administered to 508 consecutive outpatients and their clinicians in four hospital clinic sites in Hong Kong. Items in the questionnaires address adherence behaviors as well as attitudes toward medication. In addition, clinicians also estimate the presence of factors unfavorable to adherence such as substance abuse, cognitive impairments etc.
RESULTS: Non-adherence was reported in at least 26% of patients. Clinician's detection of non-adherence behaviors achieved relative high specificity (0.84) but has low sensitivity (0.33). A logistic regression analysis on patients' decision to stop medication revealed that significant predictors include patients' reported lack of perception from the benefits of medication, patients' reported negative feelings associated with regular medication and younger age.
CONCLUSION: Non-adherence is a widespread phenomenon affecting a significant proportion of outpatients under treatment. Clinicians have relatively low sensitivity in detecting which patients are non-adherent. Non-adherence behavior is predicted by level of awareness of illness, perceived benefits of medication, negative feelings toward medication and age.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636644     DOI: 10.2302/kjm.55.9

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  8 in total

Review 1.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

2.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

3.  The Effect of Paternal Age on Relapse in First-Episode Schizophrenia.

Authors:  Christy L M Hui; Cindy P Y Chiu; Yuet-Keung Li; Chi-Wing Law; Wing-Chung Chang; Sherry K W Chan; Edwin H M Lee; Pak Sham; Eric Y H Chen
Journal:  Can J Psychiatry       Date:  2015-08       Impact factor: 4.356

4.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

5.  Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.

Authors:  Wai Tong Chien; Jolene H C Mui; Eric F C Cheung; Richard Gray
Journal:  Trials       Date:  2015-06-14       Impact factor: 2.279

6.  Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia.

Authors:  Alex Z Fu; Jacqueline A Pesa; Susan Lakey; Carmela Benson
Journal:  BMC Psychiatry       Date:  2022-04-09       Impact factor: 3.630

7.  The effect of non-adherence to antipsychotic treatment on rehospitalization in patients with psychotic disorders.

Authors:  H Abdullah-Koolmees; S Nawzad; T C G Egberts; J Vuyk; H Gardarsdottir; E R Heerdink
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-25

8.  Tamoxifen-related endocrine symptoms in Chinese patients with breast cancer: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Carmen Wing Han Chan; Christine Miaskowski; Alexandra McCarthy; Mary Miu Yee Waye; Winnie Yeo; Winnie Kwok Wai So; Kai Chow Choi; Stephen Kwok Wing Tsui; Judy Yuet Wa Chan
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.